Clinical Trial Update: CAE for Poorly Adherent Individuals With Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating CAE for poorly adherent individuals with schizophrenia has completed and posted results on 2025-11-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• CAE

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Schizophrenia | NA | Status: COMPLETED | Results posted: 2025-11-18